# A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer

> **NCT04881981** · PHASE1 · UNKNOWN · sponsor: **Baptist Health, Louisville** · enrollment: 12 (estimated)

## Conditions studied

- Malignant Neoplasms

## Interventions

- **RADIATION:** SCART radiation therapy

## Key facts

- **NCT ID:** NCT04881981
- **Lead sponsor:** Baptist Health, Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-05
- **Primary completion:** 2022-05-05
- **Final completion:** 2022-05-05
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2021-05-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04881981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04881981, "A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04881981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*